Gene Therapy Medicinal Products: Non-clinical Safety Studies
Currently, gene therapy medicinal products (GTMPs) are actively developed in many countries, including the Russian Federation. However, the use of GTMPs raises class-specific safety concerns.The aim of the study was to determine the main requirements for non-clinical safety testing of GTMPs, to iden...
Saved in:
Main Authors: | O. V. Astapova (Author), A. A. Berchatova (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Antibacterial and Antiprotozoal Medicinal Products
by: E. V. Shubnikova, et al.
Published: (2022) -
Study of Safety of Medicinal Products in Pregnant Women in Crimea
by: A. V. Matveev, et al.
Published: (2021) -
Perfection of management principles by the safety signals of medicinal products
by: B. K. Romanov, et al.
Published: (2018) -
Improving the Safety of Cell Therapy Products by Suicide Gene Transfer
by: Antonio eDi Stasi, et al.
Published: (2014) -
THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
by: R. N. Alyautdin, et al.
Published: (2022)